Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis.
Kensuke IkenakaYasuhiro MaedaYuji HottaSeiichi NaganoShinichiro YamadaDaisuke ItoRyota ToriiKeita KakudaHarutsugu TatebeNaoki AtsutaCesar AguirreYasuyoshi KimuraKousuke BabaTakahiko TokudaMasahisa KatsunoKazunori KimuraGen SobueHideki MochizukiPublished in: European journal of neurology (2022)
Serum ADMA level is an independent biomarker of ALS disease progression and prognosis and reflects the degree of motor neuron degeneration.
Keyphrases